Hydroxocobalamine

This tender for Hydroxycobalamin is active and EU funded, featuring a clear description and available documentation. However, it lacks disclosed estimated value and specific evaluation criteria, impacting completeness and clarity.

The tender follows an open procedure and is EU funded, adhering to general regulatory compliance. However, the absence of a specified reveal date and explicit evaluation criteria introduces minor ambiguity regarding the procedural completeness. The provided CPV code is appropriate.

The description of the required product (Hydroxocobalamin) is clear. Key documents such as contract conditions and proposal forms are provided. However, the lack of specified evaluation criteria leaves room for interpretation for bidders.

Most basic information is present, including the title, reference, organization, and description. Contract duration is specified. However, the estimated value is not disclosed, and detailed eligibility or technical requirements are absent, which affects overall completeness.

The tender is conducted via e-procurement and all essential documents appear to be accessible, promoting fairness. The criteria for exclusion and eligibility are not explicitly detailed, which could be a concern, but the absence of company-specific requirements is positive.

The tender utilizes e-procurement, which is a positive aspect for practical submission. However, the specific URL for e-submission is not evident, and financing information is not detailed, slightly hindering practical application.

Key fields such as title, reference, organization, CPV, and deadlines are populated. There are no indicated disputes or suspensions. Dates appear logical, with the submission deadline preceding the opening date.

The tender is EU funded, indicating a level of adherence to EU standards. However, there is no explicit mention of green procurement, social aspects, or innovation within the provided information.